哈药股份 · HARBIN PHARMACEUTICAL GROUP CO., LTD.
Last · Shanghai¥7.75-0.25 (-3.13%)close · yahoo · 16h ago
Market cap¥19.5B2.52B sh
P/E · TTM38.8fwd 25.8 · eps 0.20
Beta-0.07vs S&P 500
Div yield—annual · TTM
52w range
¥2.84¥9.51
Volume503.4Msession
| Revenue | ¥12.3B |
|---|---|
| Operating income | ¥722.0M |
| Net income | ¥508.0M |
| Free cash flow | ¥112.2M |
| Operating margin | 5.9% |
| Net margin | 4.1% |
| Return on equity | 9.7% |
| Period | 2024 |
Loading chart…
Documents
FormReporting forFiledFlags